Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 84


Induction of p53 up-regulated modulator of apoptosis messenger RNA by chemotherapeutic treatment of locally advanced breast cancer.

Middelburg R, de Haas RR, Dekker H, Kerkhoven RM, Pohlmann PR, Fuentes-Alburo A, Mohar A, Pinedo HM, Lankelma J.

Clin Cancer Res. 2005 Mar 1;11(5):1863-9.


Tumor-specific adenovirus-mediated PUMA gene transfer using the survivin promoter enhances radiosensitivity of breast cancer cells in vitro and in vivo.

Wang R, Wang X, Li B, Lin F, Dong K, Gao P, Zhang HZ.

Breast Cancer Res Treat. 2009 Sep;117(1):45-54. doi: 10.1007/s10549-008-0163-6. Epub 2008 Sep 13.


Ad-PUMA sensitizes drug-resistant choriocarcinoma cells to chemotherapeutic agents.

Chen Y, Qian H, Wang H, Zhang X, Fu M, Liang X, Ma Y, Zhan Q, Lin C, Xiang Y.

Gynecol Oncol. 2007 Dec;107(3):505-12. Epub 2007 Sep 19.


Evasion of a single-step, chemotherapy-induced senescence in breast cancer cells: implications for treatment response.

Elmore LW, Di X, Dumur C, Holt SE, Gewirtz DA.

Clin Cancer Res. 2005 Apr 1;11(7):2637-43.


Genes of cell-cell interactions, chemotherapy detoxification and apoptosis are induced during chemotherapy of acute myeloid leukemia.

Øyan AM, Anensen N, Bø TH, Stordrange L, Jonassen I, Bruserud Ø, Kalland KH, Gjertsen BT.

BMC Cancer. 2009 Mar 5;9:77. doi: 10.1186/1471-2407-9-77.


The BH3-only protein PUMA is involved in green tea polyphenol-induced apoptosis in colorectal cancer cell lines.

Wang X, Wang R, Hao MW, Dong K, Wei SH, Lin F, Ren JH, Zhang HZ.

Cancer Biol Ther. 2008 Jun;7(6):902-8. Epub 2008 Mar 17.


mRNA and protein expression of PUMA in sporadic colorectal cancer.

Jansson A, Arbman G, Sun XF.

Oncol Rep. 2004 Dec;12(6):1245-9.


Analysis of gene expression identifies PLAB as a mediator of the apoptotic activity of fenretinide in human ovarian cancer cells.

Appierto V, Villani MG, Cavadini E, Gariboldi M, De Cecco L, Pierotti MA, Lambert JR, Reid J, Tiberio P, Colombo N, Formelli F.

Oncogene. 2007 Jun 7;26(27):3952-62. Epub 2007 Jan 8.


Expression profiles of apoptotic genes induced by curcumin in human breast cancer and mammary epithelial cell lines.

Ramachandran C, Rodriguez S, Ramachandran R, Raveendran Nair PK, Fonseca H, Khatib Z, Escalon E, Melnick SJ.

Anticancer Res. 2005 Sep-Oct;25(5):3293-302.


Gene expression profiles in paraffin-embedded core biopsy tissue predict response to chemotherapy in women with locally advanced breast cancer.

Gianni L, Zambetti M, Clark K, Baker J, Cronin M, Wu J, Mariani G, Rodriguez J, Carcangiu M, Watson D, Valagussa P, Rouzier R, Symmans WF, Ross JS, Hortobagyi GN, Pusztai L, Shak S.

J Clin Oncol. 2005 Oct 10;23(29):7265-77. Epub 2005 Sep 6.


Gene expression profile associated with response to doxorubicin-based therapy in breast cancer.

Folgueira MA, Carraro DM, Brentani H, Patrão DF, Barbosa EM, Netto MM, Caldeira JR, Katayama ML, Soares FA, Oliveira CT, Reis LF, Kaiano JH, Camargo LP, Vêncio RZ, Snitcovsky IM, Makdissi FB, e Silva PJ, Góes JC, Brentani MM.

Clin Cancer Res. 2005 Oct 15;11(20):7434-43.


Cell-type-specific responses to chemotherapeutics in breast cancer.

Troester MA, Hoadley KA, Sørlie T, Herbert BS, Børresen-Dale AL, Lønning PE, Shay JW, Kaufmann WK, Perou CM.

Cancer Res. 2004 Jun 15;64(12):4218-26.


Monitoring the expression profiles of doxorubicin-induced and doxorubicin-resistant cancer cells by cDNA microarray.

Kudoh K, Ramanna M, Ravatn R, Elkahloun AG, Bittner ML, Meltzer PS, Trent JM, Dalton WS, Chin KV.

Cancer Res. 2000 Aug 1;60(15):4161-6.


Specific P53 mutations are associated with de novo resistance to doxorubicin in breast cancer patients.

Aas T, Børresen AL, Geisler S, Smith-Sørensen B, Johnsen H, Varhaug JE, Akslen LA, Lønning PE.

Nat Med. 1996 Jul;2(7):811-4.


Characterization of p53-mediated up-regulation of CD95 gene expression upon genotoxic treatment in human breast tumor cells.

Ruiz-Ruiz C, Robledo G, Cano E, Redondo JM, Lopez-Rivas A.

J Biol Chem. 2003 Aug 22;278(34):31667-75. Epub 2003 Jun 4.


Immediate gene expression changes after the first course of neoadjuvant chemotherapy in patients with primary breast cancer disease.

Modlich O, Prisack HB, Munnes M, Audretsch W, Bojar H.

Clin Cancer Res. 2004 Oct 1;10(19):6418-31.


Identification of VDR-responsive gene signatures in breast cancer cells.

Towsend K, Trevino V, Falciani F, Stewart PM, Hewison M, Campbell MJ.

Oncology. 2006;71(1-2):111-23. Epub 2007 Mar 21.


Mechanism of apoptosis induced by the inhibition of fatty acid synthase in breast cancer cells.

Bandyopadhyay S, Zhan R, Wang Y, Pai SK, Hirota S, Hosobe S, Takano Y, Saito K, Furuta E, Iiizumi M, Mohinta S, Watabe M, Chalfant C, Watabe K.

Cancer Res. 2006 Jun 1;66(11):5934-40.

Supplemental Content

Support Center